Text sizeIncrease Text Size Decrease Text Size

Physician Tools

Publications

Journal Of Clinical Sleep Medicine Article
Download PDF PDF

Professional Posters

Massie C, Rosenthal L, Kram J. Acceptance and Adherence of a Novel Device in the Treatment of Sleep Apnea. Journal of Sleep and Sleep Disorders Research, Vol. 31, 2008 Abstract Supplement, p. A211.
Download PDF PDF

Colrain I, Turlington S. The Use of a Nasal Resistance Valve to Treat Sleep Disordered Breathing. Journal of Sleep and Sleep Disorders Research, Vol. 31, 2008 Abstract Supplement, p. A172.
Download PDF PDF

Rosenthal L, Dolan DC, Massie CA, et al. A Novel Expiratory Pressure Device to Treat OSA. Journal of Sleep and Sleep Disorders Research, Vol. 31, 2008 Abstract Supplement, p. A208.
Download PDF PDF

Clinical/Patient Education

PROVENT Therapy Quick Guide
Download PDF PDF

PROVENT Therapy Physician
Instructions For Use
Download PDF PDF

PROVENT Therapy Nasal Cannula Product Sheet
Download PDF PDF

PROVENT Therapy Patient Brochure
Download PDF PDF

Getting Started

While PROVENT Professional Sleep Apnea Therapy has received FDA clearance for the treatment of obstructive sleep apnea, it is only available in limited areas in the United States at this time. Please contact our Ventus Medical sales team for more information by sending an e-mail.

Register for Updates

If a patient complains of excessive daytime sleepiness, there can be a number of reasons why he may not be getting enough sleep at night. Perhaps the patient simply needs to get to bed earlier or avoid caffeine close to bedtime. But if the patient or the patient's sleep partner complains of snoring or gasping as well, it's possible that the patient suffers from obstructive sleep apnea (OSA).

Although you may need to refer the patient to a sleep center to diagnose OSA, there is a new treatment option for patients who suffer from OSA: PROVENT™ Professional Sleep Apnea Therapy.


What Is PROVENT Therapy?

PROVENT Therapy is a simple and easy-to-use treatment for OSA that eliminates the need for the cumbersome tubing, mask, and machine of continuous positive airway pressure (CPAP) therapy.

The PROVENT Nasal Device is placed just over the nostrils and is held in place by a discreet hypoallergenic adhesive. Patients discard the single use device after waking up.

For additional information on PROVENT Therapy, please contact your local Ventus Medical representative or send an e-mail.


Clinically Proven Efficacy

PROVENT Therapy has been proven effective in three clinical studies, the results of which are summarized below.2

  • In three clinical studies, there were a total of 69 subjects (59 with OSA) who participated and over 1,200 nights of study3-6
  • Significant improvements in apnea-hypopnea index (AHI), apnea index (AI), and oxygen desaturation index (ODI) achieved3-6
  • 72.4% of subjects had greater than 50% AHI reduction or treatment AHI of less than 103-6
  • In a clinical study of 28 subjects using PROVENT Therapy at home for 30 days, PROVENT Therapy was used all night on 94% of nights4,6
  • Significant improvement in Epworth Sleepiness Scale demonstrated4,6
  • Works across OSA severity, body mass index (BMI), age, gender, race3-6
  • Device effect persisted at 1 month4,6
  • Expiratory positive airway pressure (EPAP) was shown to be part of the mechanism of action5
  • OSA subjects experienced 65% reduction in snoring3
  • Only one possibly device-related adverse event (headache)3-6

Additional clinical studies at 13 sleep centers across the United States are currently ongoing.


Contraindications

Based on clinical studies involving other positive airway therapies, the PROVENT Nasal Device is contraindicated for use in patients with the following conditions:

  • Severe respiratory disorders (including respiratory muscle weakness, bullous lung disease, bypassed upper airway, pneumothorax, pneumomediastium, etc.)
  • Severe heart disease (including heart failure)
  • Pathologically low blood pressure
  • An acute upper respiratory (including nasal, sinus, or middle ear) inflammation or infection, or perforation of the tympanic membrane

Warnings

  • Assessment of effectiveness and follow-up testing and evaluation should be conducted to ensure adequate treatment effect
  • Patients who experience an allergic reaction to any part of the device should discontinue use of PROVENT Therapy and consult a physician
  • Patients who are unable to breathe through their mouth, experience excessive discomfort when breathing through the device, or experience any abnormal breathing patterns should discontinue use of PROVENT Therapy and consult a physician
  • Patients who develop nasal, sinus, or middle ear infection or inflammation should discontinue use of PROVENT Therapy and consult a physician
  • Patients who experience severe epistaxis (nose bleed) should discontinue use of PROVENT Therapy and consult a physician
  • Patients who develop skin or mucosal irritation, rash, sores, or other discomfort in or around the nose should discontinue use of PROVENT Therapy and consult a physician
  • Keep out of reach of children

Precautions

  • Patients should be instructed to breathe through their mouth while falling asleep if mouth breathing is more comfortable than nasal breathing through the device
  • The safety and effectiveness of PROVENT Professional Sleep Apnea Therapy in pregnant women, children under the age of 18, and patients with central sleep apnea has not been established
  • Patients should not use any single PROVENT Nasal Device for longer than one sleep cycle (e.g., overnight). PROVENT Therapy is intended for single use only and should be disposed of after use
  • Patients should not use PROVENT Therapy if they have any sores, abrasions, or skin or mucosal irritation on or around the entrance to the nose

Adverse Reactions

Potential adverse reactions include: increased mouth breathing while asleep, which may worsen snoring or OSA; nasal, sinus, or middle ear discomfort; nose bleed; dry mouth; nostril pain or dilation; and headache.1

References:
  1. Data on file.
  2. Data on file.
  3. Colrain IM, Brooks S, Black J. A Pilot Evaluation of a Nasal Expiratory Resistance Device for the Treatment of Obstructive Sleep Apnea. Journal of Clinical Sleep Medicine. Vol. 4, No. 5, 2008.
  4. Massie C, Rosenthal L, Kram J. Acceptance and Adherence of a Novel Device in the Treatment of Sleep Apnea. Journal of Sleep and Sleep Disorders Research, Vol. 31, 2008 Abstract Supplement, p. A211.
  5. Colrain I, Turlington S. The Use of a Nasal Resistance Valve to Treat Sleep Disordered Breathing.
    Journal of Sleep and Sleep Disorders Research, Vol. 31, 2008 Abstract Supplement, p. A172.
  6. Rosenthal L, Dolan DC, Massie CA, et al. A Novel Expiratory Pressure Device to Treat OSA.
    Journal of Sleep and Sleep Disorders Research, Vol. 31, 2008 Abstract Supplement, p. A208.

Stay up to date on Provent Therapy and Sleep Apnea